Tetrabutylammonium Fluoride → HCID 20434936, compound
Reaction equation
[CH3:1][C:2]1[CH:7]=[CH:6][NH:5][S:4](=[O:9])(=[O:8])[N:3]=1.[CH3:10][O:11][C:12]1[CH:13]=[C:14]2[C:19](=[CH:20][C:21]=1[O:22][CH3:23])[N:18]=[CH:17][N:16]=[C:15]2[N:24]1[CH2:29][CH2:28][CH:27]([CH2:30]I)[CH2:26][CH2:25]1.[F-].C([N+](CCCC)(CCCC)CCCC)CCC>>[CH3:10][O:11][C:12]1[CH:13]=[C:14]2[C:19](=[CH:20][C:21]=1[O:22][CH3:23])[N:18]=[CH:17][N:16]=[C:15]2[N:24]1[CH2:29][CH2:28][CH:27]([CH2:30][N:5]2[CH:6]=[CH:7][C:2]([CH3:1])=[N:3][S:4]2(=[O:9])=[O:8])[CH2:26][CH2:25]1Participants
4
Procedure
A mixture of 3-methyl-6H-1,2,6-thiadiazine-1,1-dioxide (0.584 g) and 1-(6,7-dimethoxyquinazolin-4-yl)-4-iodomethylpiperidine (0.826 g) were heated under reflux with tetrabutylammonium fluoride (4 ml; 1.0M in tetrahydrofuran [T.H.F.]) for 24 hours. The solvent was then removed in vacuo and the residue was chromatographed on silica (Merck 60.9385) eluting with chloroform to give a foam. Crystallisation from ethyl acetate gave 1-(6,7-dimethoxyquinazolin-4-yl)-4-(1,1-dioxo-5-methyl-1,2,6-thiadiazin-2-yl)methylpiperidine as white needles, m.p. 203°-207°, (0.35 g).
Workup
- temperaturewere heated
- customThe solvent was then removed in vacuo
- customthe residue was chromatographed on silica (Merck 60.9385)
- washeluting with chloroform
- customto give a foam
- customCrystallisation from ethyl acetate
Sources & evidence
- ORD record
- ord-f6e40673c1644acf80b405ace399bb87
- Source dataset
- uspto-grants-1984_12
- Patent number
- US04489075
Reaction notes
Loading…